pharmacy times

As the evidence base for lipid management continues to grow, understanding the timing, intensity, and duration of therapy has become crucial for optimizing patient outcomes. At the 2025 National Lipid Association (NLA) Scientific Sessions, Kausik K. Ray, MD, FMedSci, discussed the importance of early, sustained, and aggressive low-density lipoprotein cholesterol (LDL-C) lowering for atherosclerotic cardiovascular … Read more

Lp(a) Therapies⁣ Show Promise⁣ in Reducing Cardiovascular Risk Key Points Lipoprotein(a), or Lp(a), is identified ‍as an independent risk⁤ factor for heart disease. New therapies ⁤are in growth to specifically target and lower​ Lp(a) levels. Clinical trials are underway to determine if lowering lp(a) reduces cardiovascular events. Lp(a) Therapies Show Promise in Reducing Cardiovascular‌ risk … Read more

Christian Lillis of the‍ Peggy‌ Lillis foundation reveals key takeaways from the⁢ 10th National C. diff ⁣summit, spotlighting the critical role‌ of infectious disease pharmacists⁤ in combating Clostridioides ⁢difficile (C. difficile) infection. The summit underscored the changing demographics of advocates, highlighting the rise of younger⁢ voices‍ in ⁣the fight, ‍while also addressing the persistent challenges … Read more

In an interview with Pharmacy Times®, Anita Siu, PharmD, BCPPS, vice chair of teaching and learning, clinical professor, and director of faculty mentoring at the Ernest Mario School of Pharmacy, Rutgers, and Mary Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP, clinical professor at the Ernest Mario School of Pharmacy, Rutgers, explored the various types of … Read more

In an interview with Pharmacy Times®, Mary Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP, clinical professor at the Ernest Mario School of Pharmacy, Rutgers, discussed the risk factors for severe respiratory syncytial virus (RSV) disease in older adults, including chronic lung and cardiovascular conditions, immune compromise, and residence in long-term care facilities. She emphasized the … Read more

Incidence and proportion of pediatric pneumococcal complicated pneumonia (PnCP) were observed to generally decline from pre-pneumococcal conjugate vaccine (PCV) to post-PCV periods, but accurate standardization of PnCP surveillance strategies, reporting methods, and definitions are necessary to properly evaluate the impact of a PCV program, according to a systematic review and meta-analysis published in the European … Read more

Long Covid‘s Shadow: Children Face Elevated Organ Risks Table of Contents Long Covid’s Shadow: Children Face Elevated Organ Risks long covid’s shadow: children face heightened risks of chronic organ disease key findings at a glance the kidney connection gastrointestinal distress cardiovascular complications disparities across racial and ethnic groups did you know? expert outlook pro tip … Read more

Pneumococcal Vaccination: A Focused Look at Type 2 Diabetes & Immune Response Table of Contents Pneumococcal Vaccination: A Focused Look at Type 2 Diabetes & Immune Response The Complex Relationship Between Diabetes and Pneumococcal Immunity PCV10 and Type 2 Diabetes: Understanding the Immune Response & Vaccine Efficacy Why Type 2 Diabetes increases Pneumococcal Risk PCV10: … Read more

Researchers have identified that essential immune cells within the intestines prevent unwarranted attacks against harmless food allergens. These findings were published in Cell and demonstrated that in mouse models, the absence of these cells caused the subjects to experience gut inflammation and an allergic response to the food.1 Image credit: sdecoret | stock.adobe.com The intestinal … Read more

Insufficient consumption of vitamin K could adversely impact cognition as individuals age, according to research published by investigators in the Journal of Nutrition. The findings suggest that a lack of vitamin K could be linked to increased inflammation and obstruct proliferation of neural cells in the hippocampus.1,2 Image credit: pkproject | stock.adobe.com In the next … Read more